NICOLE ASHBURN: Open Payments
NPI 1336853365 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$372 in 19 payments from 4 companies in 2025. Trend: 2023 $40 · 2024 $69 · 2025 $372
Food & beverage: $372
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 7 | $147 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $142 |
| Axsome Therapeutics, Inc. | 2 | $53 |
| ABBVIE INC. | 1 | $29 |
Products named: AUSTEDO XR, CAPLYTA, Auvelity, VRAYLAR.
Industry payments across TX — which companies pay providers there.
